RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. GC Biopharma
G

GC Biopharma portfolio

GC Biopharma has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Latest deal: Curevo Vaccine · Nov 17, 2022.
About this page

Its most recent investment on record is Curevo Vaccine's Series A round in November 2022, alongside Janus Henderson Investors, RA Capital Management and Adjuvant Capital. That company is in Health and bio. It has co-invested with RA Capital Management, Janus Henderson Investors and Adjuvant Capital, most often RA Capital Management (2 rounds).

What GC Biopharma invests in

How GC Biopharma invests

StageDealsCapital in rounds
Series A 2 100%undisclosed

GC Biopharma portfolio companies

CompanyRound with GC BiopharmaTotal raisedLatest raise
CCurevo Vaccine
Health and bio
Series AundisclosedMar 18, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name GC Biopharma. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists GC Biopharma, which is a subset of its real portfolio. API: /api/v1/investors/gc-biopharma (get a free API key). More: the most active VC firms and new venture capital funds.